Ophthalmoscope Market Analysis

  • Report ID: 3999
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Ophthalmoscope Market Analysis

Application (Glaucoma, Retinal Tear, Diabetes)

The diabetes segment is estimated to hold 45% share of the global ophthalmoscope market in the coming years owing to the increasing cases of diabetes-induced blindness around the world. Patients suffering from diabetes have affected retina which can lead to blindness. This as a result rises the demand for ophthalmoscopes as it helps in the on-time detection and diagnosis of the disease. As per recent reports, diabetic retinopathy is accountable for nearly 4.5 % of blindness cases across the globe. By 2030, there will be around 640 million diabetics worldwide, and by 2045, the figure is expected to rise to over 78o million.

End- Users (Hospitals, Eye Clinics)

Ophthalmoscope market from the hospital segment is set to garner a notable gain in the near future. The growth of the segment is driven by the rising usage of ophthalmoscopes. Owing to the growing awareness of eye-related diseases more and more people are visiting hospitals that offer ophthalmic services to seek timely diagnosis and help in the management of eye-related conditions. This, as a result, has increased the demand for ophthalmoscopes on the hospital premises.

Our in-depth analysis of the global market includes the following segments:

     By End-User

  • Hospitals
  • Eye Clinics

     By Application

  • Glaucoma
  • Retinal Tear
  • Diabetes
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3999
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ophthalmoscope is evaluated at USD 274.68 million.

The ophthalmoscope market size was valued at USD 266.16 million in 2024 and is expected to reach USD 443.18 million by 2037, registering around 4% CAGR during the forecast period i.e., between 2025-2037. Rising cases of ocular diseases such as glaucoma, corneal opacification, and others will drive the market growth.

North America industry is anticipated to account for largest revenue share of 37% by 2037, impelled by growing health awareness in the region.

The major players in the market are Medline Industries, LP, Eli Lilly and Company, Bausch & Lomb Incorporated, Sun Pharmaceutical Industries Ltd., Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample